Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never-smokers

Molecular Carcinogenesis

Volumn 45, Issue 11, 2006, Pages 828-832

  Gao, Wei Min ^a   Romkes, Marjorie ^b,d   Siegfried, Jill M ^b,d   Luketich, James D ^c,d   Keohavong, Phouthone ^a,d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Lung carcinoma; Never smokers; p53 mutation; XPD polymorphism; XRCC1 polymorphism

Indexed keywords

ADENINE; ARGININE; CYTOSINE; GLUTAMINE; GUANINE; PROTEIN P53; THYMINE;

ADULT; AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; DNA REPAIR; EXCISION REPAIR; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; LUNG CARCINOGENESIS; LUNG CARCINOMA; MALE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; STATISTICAL SIGNIFICANCE; TOBACCO; TUMOR SUPPRESSOR GENE; WILD TYPE; XPD GENE; XRCC1 GENE;

ALLELES; DNA REPAIR; DNA-BINDING PROTEINS; GENE FREQUENCY; GENOTYPE; HUMANS; LUNG NEOPLASMS; MUTATION; POLYMORPHISM, GENETIC; SMOKING; TUMOR SUPPRESSOR PROTEIN P53; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

NICOTIANA TABACUM;

EID: 33750461289     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20208     Document Type: Article

References (23)

1. ACS. Cancer facts and figures-2002. American Cancer Society; 2002.
2. Kabat GC. Aspects of the epidemiology of lung cancer in smokers and nonsmokers in the United States. Lung Cancer 1996;15:1-20.
3. Fontham ET, Correa P, WuWilliams A, et al. Lung cancer in nonsmoking women: A multicenter case-control study. Cancer Epidemiol Biomarkers Prev 1991;1:35-43.
4. Mumford JL, He XZ, Chapman RS, et al. Lung cancer and indoor air pollution in Xuan Wei, China. Science 1987;235:217-220.
5. Taioli E, Wynder EL. Re: Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 1994;86:869-870.
6. Ernster VL. The epidemiology of lung cancer in women. Ann Epidemiol 1994;4:102-110.
7. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-4878.
8. Gealy R, Zhang L, Siegfried JM, Luketich JD, Keohavong P. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Cancer Epidemiol Biomarkers Prev 1999;8:297-302.
9. Hainaut P, Pfeifer GP. Patterns of p53 G → T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis 2001;22:367-374.
10. Hernandez-Boussard TM, Hainaut P. A specific spectrum of p53 mutations in lung cancer from smokers: Review of mutations compiled in the IARC p53 database. Environ Health Perspect 1998;106:385-391.
11. Gao WM, Romkes M, Day RD, et al. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer. Carcinogenesis 2003;24:1671-1676.
12. Ratnasinghe D, Yao SX, Tangrea JA, et al. Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:119-123.
13. Spitz MR, Wu X, Wang Y, et al. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 2001;61:1354-1357.
14. Butkiewicz D, Rusin M, Enewold L, Shields PG, Chorazy M, Harris CC. Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis 2001;22:593-597.
15. Divine KK, Gilliland FD, Crowell RE, et al. The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung. Mutat Res 2001;461:273-278.
16. Gao WM, Mady HH, Yu GY, et al. Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung: Unique spectra involving G to A transitions and G to T transversions in both histologic types. Lung Cancer 2003;40:141-150.
17. Keohavong P, DeMichele MA, Melacrinos AC, Landreneau RJ, Weyant RJ, Siegfried JM. Detection of K-ras mutations in lung carcinomas: Relationship to prognosis. Clin Cancer Res 1996;2:411-418.
18. Rideout WM III, Coetzee GA, Olumi AF, Jones PA. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 1990;249:1288-1290.
19. Husgafvel-Pursiainen K, Boffetta P, Kannio A, et al. p53 mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer. Cancer Res 2000;60:2906-2911.
20. Benhamou S, Sarasin A. Variability in nucleotide excision repair and cancer risk: A review. Mutat Res 2000;462:149-158.
21. Lindahl T. Instability and decay of the primary structure of DNA. Nature 1993;362:709-715.
22. Wilson DM III, Thompson LH. Life without DNA repair. Proc Natl Acad Sci USA 1997;94:12754-12757.
23. Beckman KB, Ames BN. Oxidative decay of DNA. J Biol Chem 1997;272:19633-19636.